Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Top Pharma and Biotech firms Trust CompacT Automated Cell Culture to Generate their Cell Lines

Published: Friday, January 11, 2013
Last Updated: Friday, January 11, 2013
Bookmark and Share
See the System at SLAS on TAP Biosystems’ Booth #712 to find out why.

TAP Biosystems announced that with its latest installation of CompacT SelecT™, the technology remains the most widely adopted system for automated culture of adherent cell lines in T-flasks, used by major pharmaceutical and biotech companies worldwide. On Booth #712 at the Society for Laboratory Automation and Screening (SLAS) 2013 there is a unique opportunity to see the CompacT SelecT in action.

The CompacT SelecT systems installed in these leading companies offer parallel, aseptic cell culture processing in T75 and T175 flasks at any time of day or night, without scientists having to be present, thus providing a continuous supply of consistent quality cells for use in cell-based screening programmes.

The systems sited have each been tailored with a range of options which allow tasks such as automated cell imaging and analysis, control of culture conditions, media additions and passaging of immortalised, primary cells or stem cells. The cells are being used in applications including high throughput screening, lead optimisation, assay development, target identification and validation, as well as toxicity studies. The stem cell lines are being utilised to support research in therapeutic areas such as oncology and neurology.

The CompacT SelecT system will be on Booth #712 at SLAS2013. To book a demonstration time and find out more about the system options from TAP’s cell culture experts, please contact Matt Walker by email on matthew.walker@tapbiosystems.com.

Dr Dave Thomas, Product Manager at TAP Biosystems stated: "With the number of automated cell culture technologies increasing, we are pleased that our CompacT SelecT system has become the system of choice in the top pharma and biotech companies. Many of these firms now have multiple systems installed at their North American and European sites and a number are looking to place them in their new Asian drug discovery facilities.”

Thomas added: "The adoption of the CompacT SelecT systems by these leading companies is an excellent endorsement that the technology’s performance capabilities perfectly match their rigorous cell culture demands. Any pharma or biotech scientists looking for a proven and trusted method of consistently generating high quality cell lines should visit us on Booth #712 at SLAS, to discover how a CompacT SelecT system would help them to achieve reproducible results in their cell-based research and development programmes.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors
Presents validation data for improving media screening and process optimization.
Friday, February 14, 2014
TAP Biosystems Presents New Data on 3D Cell Culture Research
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
Monday, January 20, 2014
Collaboration between TAP Biosystems and UCL to Develop Biomimetic 3D Cancer Models
TAP Biosystems announced new collaboration to develop solid tumour tissue models using its RAFT 3D cell culture system for use in drug discovery applications.
Friday, October 12, 2012
Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Most Complete Human Brain Model to Date is a ‘Brain Changer’
Once licensed, model likely to accelerate study of Alzheimer’s, autism, more.
Capturing Cell Growth in 3-D
Spinout’s microfluidics device better models how cancer and other cells interact in the body.
Protein That Turns Moles Into Melanoma Cancer Identified
Moles can turn into cancer, if the genetic factors recently identified by a team of researchers at the University of Pennsylvania were not present in humans.
Scientists Grow Human Serotonin Neurons in Petri Dish
The advance could facilitate the discovery of new antidepressants and drugs for illnesses involving serotonin.
Study Details Powerful Molecular Promoter of Colon Cancers
Findings show how suppression of microRNA family of molecules leads to intestinal tumors.
From Pluripotency to Totipotency
Studies results provide new elements for the understanding of pluripotency and could increase the efficiency of reprogramming somatic cells to be used for applications in regenerative medicine.
Cancer Treatment Models get Real
Researchers at Rice Univ. and Univ. of Texas MD Anderson Cancer Center have developed a way to mimic the conditions under which cancer tumors grow in bones.
Potential Treatment for Muscular Dystrophy
A new method for producing muscle cells could offer a better model for studying muscle diseases, such as muscular dystrophy, and for testing potential treatment options.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!